NRC Health announced its second quarter 2024 results, with revenue of approximately $35 million and earnings per diluted share of $0.26. The company also completed an amendment to its credit agreement and acquired NOBL Health.
Revenue for the quarter was approximately $35 million, compared to $36 million in the same quarter of 2023.
Earnings per diluted share were $0.26, down from $0.29 in the second quarter of 2023.
Net indebtedness was approximately $42 million as of June 30, 2024.
Total recurring contract value (TRCV) was approximately $138 million at June 30, 2024.
The company has elected to include strategic updates normally discussed in earning calls to a broader group of current and potential stockholders via its quarterly earnings releases.
Analyze how earnings announcements historically affect stock price performance